Literature DB >> 14680834

Inhibition of P-selectin-mediated cell adhesion by a sulfated derivative of sialic acid.

Tomonori Shodai1, Junsuke Suzuki, Sanae Kudo, Saotomo Itoh, Masaki Terada, Shuji Fujita, Hajime Shimazu, Tsutomu Tsuji.   

Abstract

P-selectin, a carbohydrate-binding cell adhesion molecule expressed on activated endothelial cells and platelets, plays a key role in the recruitment of leukocytes to inflammatory and hemorrhagic sites. It simultaneously recognizes a sialic acid-containing carbohydrate chain and the sulfated tyrosine residues of a specific counter-receptor expressed on the leukocyte surface. We examined the inhibitory effects of a synthetic sulfated derivative of sialic acid (NMSO3) on P-selectin-mediated cell adhesion and found the following: (1) P-selectin/IgG chimera bound to immobilized NMSO3. (2) The binding of P-selectin/IgG chimera to purified P-selectin glycoprotein ligand-1 was inhibited by soluble NMSO3. (3) The adhesion of HL60 cells to P-selectin-expressing CHO cells was inhibited by NMSO3. (4) NMSO3 inhibited P-selectin-induced tumor necrosis factor-alpha production in monocytes and activated platelet-induced generation of reactive oxygen species in neutrophils. In conclusion, NMSO3 acts as a specific inhibitor for P-selectin-mediated cell adhesion and for adhesion-dependent leukocyte activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14680834     DOI: 10.1016/j.bbrc.2003.10.188

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Development of liposomal nanoconstructs targeting P-selectin (CD62P)-expressing cells by using a sulfated derivative of sialic acid.

Authors:  Saotomo Itoh; Kumi Kawano; Kana Takeshita; Yoshie Maitani; Tsutomu Tsuji
Journal:  Pharm Res       Date:  2014-05-03       Impact factor: 4.200

2.  Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer.

Authors:  Keith Meyer; Aster Beyene; Terry L Bowlin; Arnab Basu; Ranjit Ray
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 3.  Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer.

Authors:  Alejandro J Cagnoni; Juan M Pérez Sáez; Gabriel A Rabinovich; Karina V Mariño
Journal:  Front Oncol       Date:  2016-05-13       Impact factor: 6.244

4.  Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases.

Authors:  Cédric Chauvierre; Rachida Aid-Launais; Joël Aerts; Frédéric Chaubet; Murielle Maire; Lucas Chollet; Lydia Rolland; Roberta Bonafé; Silvia Rossi; Simona Bussi; Claudia Cabella; Laszlo Dézsi; Tamas Fülöp; Janos Szebeni; Youssef Chahid; Kang H Zheng; Erik S G Stroes; Dominique Le Guludec; François Rouzet; Didier Letourneur
Journal:  Mar Drugs       Date:  2019-12-12       Impact factor: 5.118

Review 5.  Aberrant Sialylation in Cancer: Therapeutic Opportunities.

Authors:  Jennifer Munkley
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

6.  Effect of NMSO3 treatment in a murine model of human metapneumovirus infection.

Authors:  Leanne Spetch; Terry L Bowlin; Antonella Casola
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

Review 7.  Insights into the role of sialylation in cancer progression and metastasis.

Authors:  Christopher Dobie; Danielle Skropeta
Journal:  Br J Cancer       Date:  2020-11-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.